GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | EGF | decreases expression | EXP | | 6480464 | CTD | bisphenol A results in decreased expression of EGF mRNA | PMID:31230753 | EGF | increases expression | EXP | | 6480464 | CTD | bisphenol A results in increased expression of EGF mRNA | PMID:30022450 | EGF | increases secretion | EXP | | 6480464 | CTD | bisphenol A results in increased secretion of EGF protein | PMID:30022450 | EGF | decreases expression | ISO | Egf (Rattus norvegicus) | 6480464 | CTD | bisphenol A results in decreased expression of EGF mRNA | PMID:25181051 | EGF | increases expression | ISO | Egf (Mus musculus) | 6480464 | CTD | bisphenol A results in increased expression of EGF mRNA | PMID:11011959 PMID:32353937 | EGF | increases expression | ISO | Egf (Rattus norvegicus) | 6480464 | CTD | bisphenol A results in increased expression of EGF mRNA | PMID:31771501 | EGF | increases methylation | ISO | Egf (Rattus norvegicus) | 6480464 | CTD | bisphenol A results in increased methylation of EGF gene | PMID:28505145 | EGF | multiple interactions | ISO | Egf (Rattus norvegicus) | 6480464 | CTD | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of EGF mRNA | PMID:25607892 | | ||||||||||||||||||||||
| Go Back to source page | Continue to Ontology report |